The closing price of Applied Therapeutics Inc (NASDAQ: APLT) was $7.40 for the day, up 32.62% from the previous closing price of $5.58. On the day, 13506260 shares were traded.
Ratios:
Our analysis of APLT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.80 and its Current Ratio is at 0.80.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on February 22, 2024, initiated with a Outperform rating and assigned the stock a target price of $12.
On January 04, 2022, Barclays Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $44 to $7.
Goldman Downgraded its Neutral to Sell on August 27, 2021, whereas the target price for the stock was revised from $16 to $10.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 01 when Kanter Stacy J. bought 30,000 shares for $2.18 per share. The transaction valued at 65,367 led to the insider holds 63,000 shares of the business.
Shendelman Shoshana sold 3,968 shares of APLT for $7,817 on Nov 30. The President and CEO now owns 2,596,387 shares after completing the transaction at $1.97 per share. On Nov 30, another insider, Perfetti Riccardo, who serves as the Chief Medical Officer of the company, sold 1,583 shares for $1.97 each. As a result, the insider received 3,119 and left with 692,341 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLT now has a Market Capitalization of 571.50M and an Enterprise Value of 535.35M. For the stock, the TTM Price-to-Sale (P/S) ratio is 53.61. Its current Enterprise Value per Revenue stands at 50.22 whereas that against EBITDA is -8.63.
Stock Price History:
The Beta on a monthly basis for APLT is 1.69, which has changed by 482.46% over the last 52 weeks, in comparison to a change of 27.55% over the same period for the S&P500. Over the past 52 weeks, APLT has reached a high of $6.20, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is 3.25, while the 200-Day Moving Average is calculated to be 2.20.
Shares Statistics:
APLT traded an average of 2.01M shares per day over the past three months and 4.33M shares per day over the past ten days. A total of 77.23M shares are outstanding, with a floating share count of 52.95M. Insiders hold about 31.43% of the company’s shares, while institutions hold 71.39% stake in the company. Shares short for APLT as of Feb 15, 2024 were 3.87M with a Short Ratio of 1.92, compared to 3.63M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.01% and a Short% of Float of 5.96%.
Earnings Estimates
The firm’s stock currently is rated by 4 analysts. On average, analysts expect EPS of -$0.24 for the current quarter, with a high estimate of -$0.15 and a low estimate of -$0.34, while EPS last year was -$0.16. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.15 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$1.2 and -$1.76 for the fiscal current year, implying an average EPS of -$1.43. EPS for the following year is -$0.87, with 4 analysts recommending between -$0.58 and -$1.21.
Revenue Estimates
Based on 4 analysts’ estimates, the company’s revenue will be $13.95M in the next fiscal year. The high estimate is $25.28M and the low estimate is $6.28M. The average revenue growth estimate for next year is up 30.70% from the average revenue estimate for this year.
